CVE-2019-3994

Public Exploit

Description

ELOG 3.1.4-57bea22 and below is affected by a denial of service vulnerability due to a use after free. A remote unauthenticated attacker can crash the ELOG server by sending multiple HTTP POST requests which causes the ELOG function retrieve_url() to use a freed variable.

Category

7.5
CVSS
Severity: High
CVSS 3.1 •
CVSS 2.0 •
EPSS 2.80% Top 15%
Vendor Advisory fedoraproject.org Vendor Advisory fedoraproject.org
Affected: n/a ELOG
Published at:
Updated at:

References

Link Tags
https://www.tenable.com/security/research/tra-2019-53 third party advisory exploit
https://lists.fedoraproject.org/archives/list/package-announce%40lists.fedoraproject.org/message/2IN3FP6VXYSD4OMUCFZNOL7MKPWRQFAL/ vendor advisory
https://lists.fedoraproject.org/archives/list/package-announce%40lists.fedoraproject.org/message/4IAS4HI24H2ERKBZTDEVJ3LEQEFWYSCT/ vendor advisory

Frequently Asked Questions

What is the severity of CVE-2019-3994?
CVE-2019-3994 has been scored as a high severity vulnerability.
How to fix CVE-2019-3994?
To fix CVE-2019-3994, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2019-3994 being actively exploited in the wild?
It is possible that CVE-2019-3994 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~3% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2019-3994?
CVE-2019-3994 affects n/a ELOG.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.